Increasing Awareness Regarding the Animal Health Are Anticipated to Boost the Adjuvants Market

Increasing Incidences of the Zoonotic Diseases and Increasing Awareness Regarding the Animal Health are Anticipated to Boost The Adjuvants Market During The Forecast Period. Adjuvants market size is forecast to reach $1.9 billion by 2026, growing at a CAGR of 4.5% during the forecast period 2021-2026.

The Adjuvants market is growing at a significant rate owing to the increasing prevalence of the zoonotic diseases. Zoonotic diseases includes bird flu, animal flu, and brucellosis among others. Infections like campylobacter are transmitted from animals to the humans and vice versa. According to the Disease Control and Prevention, 6 out of 10 infectious diseases are transmitted to the humans from the animals and for treating these zoonotic diseases, various vaccines are used.

Adjuvants are the substances that are used for enhancing the immunogenicity of an antigen. The innate immune system responds extremely rapidly to infection and adaptive immune response becomes more specific. It acts on both animals as well as plants having wide range of applications and enhances the ability and protect against the infections. Naturally occurring pathogens helps in triggering non-specific immune responses to the vaccines by targeting various receptors on the surface of the immune cells. Adjuvants are used in all types of medicines and for treating diseases including influenza, and viruses among others. Increasing investment in research & development activities of various types of adjuvants and increasing usage of adjuvants for treating animal diseases are increasing the growth of the market. Vaccine adjuvants are immune potentiators that helps in activating the immune recognition pathways. It also helps in developing superior immune system in patients and enhances the potency of the vaccines. Aluminium salt based adjuvants and emulsion adjuvants are the most commonly used vaccine adjuvants that are used for enhancing the duration and the speed of the immune system. Adjuvants are also used to produce antibodies that are used for diagnostic procedures and are most commonly used in the production of the polyclonal antibodies. It also protects the antigen from the proteolytic destruction and preserves the conformational integrity of the antigens. Immunomodulators are used for enhancing the differentiation of the cells of the immune system.

North America dominated the global market share of the adjuvants market in 2020 owing to the increasing research & development, and increasing penetration of improved medication. The demand for adjuvant market is increasing along with the increasing availability of various treatments, increasing incidences of the zoonotic diseases, and improving healthcare infrastructure. The rapid growth of the vaccine adjuvants segment is driving the demand for adjuvant market. All these factors are set to avail new growth opportunities to the adjuvants market in the region during 2021-2026.

Increasing demand of adjuvants in medical and pharmacy is increasing the growth of the Adjuvants Market. Adjuvants are used in all types of medicines as an additive and for treatment of diseases such as influenza, and virus among others. Adjuvants are also used to produce antibodies that are used for diagnostic procedures and are most commonly used in the production of the polyclonal antibodies. It also protects the antigen from the proteolytic destruction and preserves the conformational integrity of the antigens. Immunomodulators are used for enhancing the differentiation of the cells of the immune system.

Increasing focus on several vaccination drives by various government bodies is increasing the growth of the Adjuvants Market. Increasing research & development, technological advancements in formulations of adjuvants, and increasing adoption rate of the recombinant vaccines is increasing the growth of the market. Stringent government regulations and the availability of limited number of adjuvants is hindering the growth of the market. However, the advantages of adjuvants significantly outweigh the disadvantages.

In May 2020, GSK produces 1 billion doses of its pandemic vaccine adjuvant system in 2021 for supporting the development of multiple adjuvanted COVID-19 vaccine candidates. Thus, the COVID-19 pandemic is set to impact the growth of the Adjuvants Market during the forecast period 2021-2026.

The major companies in the Adjuvants market include BASF SE, Bayer CropScience AG, Koppert Biological Systems B.V., Marrone Bio Innovations, Andermatt Biocontrol AG, and Monsanto Company Inc. among others.

Over the years, major market players have focused on different adjuvants that were typically used to treat various diseases. The launch of new market companies, adequate funding, and government-aided policies help in the development of adjuvants products. The continuous developments in the Adjuvants Market such as advanced technologies, increasing funding amount of startups and research organizations, and surge in the number of product and vaccine adjuvants products are the major factors set to drive the Adjuvants market during the forecast period 2021-2026.